Kotak Alts Invests INR 40 Cr in Mediversal Healthcare to Drive Eastern India Expansion

The funding will support Mediversal’s organic and inorganic expansion plans across Eastern India, including new facilities in Bihar and neighboring regions.

Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Science Fund I, has invested INR 40 crore in Mediversal Healthcare, a Patna-based multi-specialty hospital chain.

The round also saw participation from Asha Ventures, an impact-focused fund.

The funding will support Mediversal’s organic and inorganic expansion plans across Eastern India, including new facilities in Bihar and neighboring regions. Founded in 2020 by Navneet Ranjan, Bhanu Pratap, and Jayant Gandhi, Mediversal operates a 200+ bed hospital in Patna and focuses on delivering accessible, patient-centric care.

The hospital group holds Full NABH Certification, IDCCM & IDCCN Compliance, and CAHO ACE Accreditation—making it one of the few institutions in Eastern India with these credentials.

Bhanu Pratap, Co-Founder & CEO of Mediversal Healthcare, said, “This investment accelerates our expansion across Bihar and Eastern India. We are opening new hospitals to serve underserved communities with dignified care closer to home. It also strengthens our technological backbone, enabling us to scale seamlessly and uphold consistent standards at every location. Clinical excellence with a human touch remains our defining strength, guided by values of Trust, Transparency, and Care.”

Mediversal has served over 60,000 patients in the last year across both urban and rural areas in Eastern India, reflecting its growing presence and focus on improving healthcare access in the region.

Stay tuned for more such updates on Digital Health News